ArticleCancers2018

Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease.

Annkathrin Hanssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.